MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
49.67
-1.20 (-2.35%)
At close: Jul 15, 2025, 4:00 PM
49.67
+0.01 (0.01%)
After-hours: Jul 15, 2025, 4:00 PM EDT

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $3.15 billion. The enterprise value is $2.74 billion.

Market Cap 3.15B
Enterprise Value 2.74B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, before market open.

Earnings Date Aug 6, 2025
Ex-Dividend Date n/a

Share Statistics

MLTX has 63.47 million shares outstanding. The number of shares has increased by 14.55% in one year.

Current Share Class 63.47M
Shares Outstanding 63.47M
Shares Change (YoY) +14.55%
Shares Change (QoQ) +0.26%
Owned by Insiders (%) 10.95%
Owned by Institutions (%) 50.94%
Float 28.34M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.92
P/TBV Ratio 7.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 21.11, with a Debt / Equity ratio of 0.18.

Current Ratio 21.11
Quick Ratio 20.15
Debt / Equity 0.18
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -9,486.45

Financial Efficiency

Return on equity (ROE) is -30.64% and return on invested capital (ROIC) is -20.44%.

Return on Equity (ROE) -30.64%
Return on Assets (ROA) -19.85%
Return on Invested Capital (ROIC) -20.44%
Return on Capital Employed (ROCE) -35.04%
Revenue Per Employee n/a
Profits Per Employee -$1.45M
Employee Count 100
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $365,199 in taxes.

Income Tax 365,199
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.02% in the last 52 weeks. The beta is 1.27, so MLTX's price volatility has been higher than the market average.

Beta (5Y) 1.27
52-Week Price Change +8.02%
50-Day Moving Average 43.59
200-Day Moving Average 45.33
Relative Strength Index (RSI) 64.29
Average Volume (20 Days) 426,927

Short Selling Information

The latest short interest is 6.07 million, so 9.57% of the outstanding shares have been sold short.

Short Interest 6.07M
Short Previous Month 6.12M
Short % of Shares Out 9.57%
Short % of Float 21.43%
Short Ratio (days to cover) 9.81

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -170.76M
Pretax Income -58.02M
Net Income -145.21M
EBITDA -169.32M
EBIT -170.76M
Earnings Per Share (EPS) -$2.30
Full Income Statement

Balance Sheet

The company has $480.13 million in cash and $75.60 million in debt, giving a net cash position of $404.53 million or $6.37 per share.

Cash & Cash Equivalents 480.13M
Total Debt 75.60M
Net Cash 404.53M
Net Cash Per Share $6.37
Equity (Book Value) 412.58M
Book Value Per Share 6.42
Working Capital 482.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$139.78 million and capital expenditures -$342,520, giving a free cash flow of -$140.12 million.

Operating Cash Flow -139.78M
Capital Expenditures -342,520
Free Cash Flow -140.12M
FCF Per Share -$2.21
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.55%
Shareholder Yield -14.55%
Earnings Yield -4.61%
FCF Yield -4.45%
Dividend Details

Analyst Forecast

The average price target for MLTX is $73.33, which is 47.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target $73.33
Price Target Difference 47.65%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 15.26%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1